Inhaled corticosteroid is not associated with a poor prognosis in COVID-19

Tai Joon An¹, Youlim Kim², Yong Bum Park³, Kyungjoo Kim⁴, Do Yeon Cho⁵, Kwang-Ha Yoo⁶, Chin Kook Rhee⁴

Affiliations

¹ Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
² Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Republic of Korea.
³ Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Republic of Korea.
⁴ Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
⁵ Big Data Research Division, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.
⁶ Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University Hospital, School of Medicine, Konkuk University, Seoul, Republic of Korea.

PMID: 34173692
PMCID: PMC8447022
DOI: 10.1111/resp.14108

Comment

Inhaled corticosteroid is not associated with a poor prognosis in COVID-19

Tai Joon An et al. Respirology. 2021 Aug.

. 2021 Aug;26(8):812-815.

doi: 10.1111/resp.14108. Epub 2021 Jun 26.

Authors

Tai Joon An¹, Youlim Kim², Yong Bum Park³, Kyungjoo Kim⁴, Do Yeon Cho⁵, Kwang-Ha Yoo⁶, Chin Kook Rhee⁴

Affiliations

¹ Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
² Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Republic of Korea.
³ Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Republic of Korea.
⁴ Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
⁵ Big Data Research Division, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.
⁶ Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University Hospital, School of Medicine, Konkuk University, Seoul, Republic of Korea.

PMID: 34173692
PMCID: PMC8447022
DOI: 10.1111/resp.14108

Abstract

Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.

Keywords: COVID-19; SARS-CoV-2; coronavirus disease; inhaled corticosteroid; prognosis.

PubMed Disclaimer

Conflict of interest statement

Chin Kook Rhee has received consulting/lecture fees from MSD, AstraZeneca, GSK, Novartis, Takeda, Mundipharma, Boehringer‐Ingelheim, Teva, Sanofi and Bayer. Other authors have no conflict of interest.

Comment on

Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.
Schultze A, Walker AJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, Rentsch CT, Williamson E, Drysdale H, Croker R, Bacon S, Hulme W, Bates C, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, Tomlinson L, Mathur R, Wing K, Wong AYS, Forbes H, Parry J, Hester F, Harper S, Evans SJW, Quint J, Smeeth L, Douglas IJ, Goldacre B; OpenSAFELY Collaborative. Schultze A, et al. Lancet Respir Med. 2020 Nov;8(11):1106-1120. doi: 10.1016/S2213-2600(20)30415-X. Epub 2020 Sep 24. Lancet Respir Med. 2020. PMID: 32979987 Free PMC article.

References

1. Lee J, Lee JH, Kim JA, Rhee CK. Trend of cost and utilization of COPD medication in Korea. Int J Chron Obstruct Pulmon Dis. 2017;12:27–33. - PMC - PubMed
1. Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID‐19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009. - PMC - PubMed
1. Kim L, Kim JA, Kim S. A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples. Epidemiol Health. 2014;36:e2014008. - PMC - PubMed
1. Choi JY, Yoon HK, Lee JH, Yoo KH, Kim BY, Bae HW, et al. Nationwide use of inhaled corticosteroids by South Korean asthma patients: an examination of the Health Insurance Review and Service database. J Thorac Dis. 2018;10:5405–13. - PMC - PubMed
1. Kim JA, Lim MK, Kim K, Park J, Rhee CK. Adherence to inhaled medications and its effect on healthcare utilization and costs among high‐grade chronic obstructive pulmonary disease patients. Clin Drug Investig. 2018;38:333–40. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Inhaled corticosteroid is not associated with a poor prognosis in COVID-19

Affiliations

Inhaled corticosteroid is not associated with a poor prognosis in COVID-19

Authors

Affiliations

Abstract

Conflict of interest statement

Comment on

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous